Skip to content

Recovery Evaluation App for Comprehensive Treatment support – a prospective feasibility study

Recovery Evaluation App for Comprehensive Treatment support – a prospective feasibility study - REACT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00038268
Enrollment
120
Registered
2026-01-07
Start date
2026-03-02
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25 C22 C24 C15

Interventions

Group 1: Adult patients who underwent major surgery (pancreas, liver, esophagus, or sarcoma surgery) within a standardized perioperative care programme at the University Medical Center Hamburg-Eppendo

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Previous surgical procedure (pancreas, liver, esophagus, or sarcoma) performed within a standardized ERAS protocol (within the last 36 months), with a signed biobank consent form available (PV3548). • Capacity to provide informed consent. • Agreement to be contacted and to participate in the study.

Exclusion criteria

Exclusion criteria: • Severe cognitive impairments. • Language barriers if the app and questionnaire are not understandable. • No possibility to use digital devices (smartphone, tablet, or PC).

Design outcomes

Primary

MeasureTime frame
Perceived usefulness of the app for optimizing the recovery process within the ERAS concept (assessed retrospectively) (TAM-PU and ERAS-specific questionnaires). time point: single assessment after completion of recovery at the time of study participation, 1–36 months after surgery; measured using TAM-PU and ERAS-specific questionnaires).

Secondary

MeasureTime frame
Usability and user-friendliness of the app measured using the G-MAUQ. Technical issues (e.g., app crashes). Affinity for Technology Interaction (ATI). Evaluation of individual content components (e.g., videos, daily goals, interactive features) using uMARS. Participants’ suggestions for improvement. Response rate and dropout rate as measures of feasibility. Qualitative assessment of the app by the ERAS team (medical and nursing staff) using MARS. Qualitative assessment of the app by patients using uMARS.

Countries

Germany

Contacts

Public ContactValerie Nottberg

Universitätsklinikum Hamburg-Eppendorf

v.nottberg@uke.de+4904074100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026